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S6 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5METHODS From the IRIS-DES registry, we identiﬁed 683 patients
treated using stent with ST-elevation myocardial infarction (STEMI)
who had multivessel disease. A total 212 patients was underwent
infarct-artery percutaneous coronary intervention (PCI) alone, and a
471 patients was underwent preventive PCI. Major adverse cardiac
events (MACE) were deﬁned using composite of death, myocardial
infarction, and target vessel revascularization (TVR).
RESULTS During follow up (median 2 years), culprit only PCI versus
preventive PCI was no signiﬁcant difference in MACE cumulative
incidence(11.4% vs. 12.5%, Hazard ratio[HR], 95% conﬁdence interval
[CI] 0.89 (0.55 – 1.45), P ¼ 0.652), death (6.0% vs. 7.1%, 0.86 (0.45 –
1.65), P ¼ 0.653), MI (1.6% vs. 7.1%, 1.11 (0.27 – 4.60), P ¼ 0.876), and
TVR (8.5% vs. 12.0%, 0.65 (0.38 – 1.12), P ¼ 0.121). The cumulative
rates of Academic Research Consortium deﬁned deﬁnite stent
thrombosis were 1.0% in Only culprit PCI group and 0.9% in preven-
tive PCI group (P ¼ 0.901).
CONCLUSION In our registry study, the preventive PCI in STEMI
cannot contribute to improve clinical outcome, including death, MI,
and TVR. A preventive angioplasty strategy of nonculprit lesions in
STEMI remains controversial.
Table 1. Characteristics of Study Patients Undergoing PCI of the ULMCANo AOC (N[238) AOC (N[623) P-valueAge (years) 62.3410.97 63.929.47 0.231
Gender (Male) 45(18.9) 174(27.9) 0.007Hypertension 144(60.5) 356(57.1) 0.371Diabetes 85(35.7) 216(34.7) 0.774LV ejection fraction (%) 57.39.72 59.67.64 0.035
Aorto-ostial lesion 5(2.1) 307(49.3) 0.001At least one chronic total occlusion 7(2.9) 6(1) 0.033At least one severe calciﬁcation 14(5.9) 21(3.4) 0.095At least one thrombus present 12(5) 26(4.2) 0.579At least one ulceration 11(4.6) 13(2.1) 0.043Reference diameter (mm) 3.580.44 3.70.42 0.001
Lumen diameter stenosis (%) 61.8332.8 64.7926.5 0.171
Total number of stents 2.891.4 2.681.5 0.301
Total stent length 70.3239.7 63.0838.1 0.158
Maximal balloon inﬂation size 3.940.3 4.080.4 0.004Data are N (%), meanSD; AOC, aorto-ostial coverageTCTAP A-010
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BACKGROUND Acute coronary syndrome (ACS) refers to symptoms
attributed to obstruction of the coronary arteries, and is associated
with coronary thrombosis. In ACS patients, revascularization within
the time of guideline recommendation is critical to improve prog-
nosis, where in real situation, however, patients with appropriate
treatment are minor. Diagnostic dilemma is one of the important
reasons of reperfusion delay. Despite well trained physicians and
diagnostic tools, diagnosing ACS early in the emergency department
(ED) remains a challenge. In this study, we investigate the possi-
bility of predicting ACS using machine learning algorithms at an
early stage using clinical and laboratory data in patients who pre-
sented a chest pain at admission of emergency room or outpatients
clinic.
METHODS We obtained 2,344 ACS patient and 6289 non-ACS patient
data, and 27 features are selected for ACS prediction. Among the non-
ACS, patients, coronary artery spasm (CAS) was 2,738 patients. A
standard algorithm, linear discriminant analysis (LDA) is used for
prediction, and the classiﬁcation accuracy of ACS and non-ACS pa-
tients is reported as well as the analysis which features are more
relevant. Based on the feature pattern and ﬁlter characteristics, we
can analyze which features possess the discriminative information
while other features help improve accuracy by reducing noise of
features with discriminative information.
RESULTS The accuracy of classiﬁcation is average of 0.81 for non-
trained data, and we could select relevant features of classiﬁcation as
well as the features without discriminative information but reducing
noise of relevant features. Even when we eliminate the relevant fea-
tures chosen at ﬁrst stage, the less-informative features still have
discriminative information achieving the accuracy of 0.81.
CONCLUSION The risk group of ACS patients can be selected
before emergency using prediction algorithm, and the accuracy is
high. However, in this study, there were several missing data,
which is related to predict ACS. Therefore, in the future, a large
cohort study without missing data should be needed to get a ﬁnal
result.
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BACKGROUND It is reported that emergency procedure and two-stent
procedure at the bifurcation lesion are high risk factors for sub-acute
stent thrombosis (SAT). However, the impacts of presence or absence of
ST-segment elevation in acute coronary syndrome (ACS) patients and
two-stent procedure in those patients are little known. We compared
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infarction (STEMI), non-ST-segment elevation ACS (NSTE-ACS) and
elective patient sand investigated the impact of two-stent procedure.
METHODS From January 2001 to December 2013, percutaneous coro-
nary intervention was performed in 2241 STEMI, 3098 NSTE-ACS, and
13392 elective patients, in whom the incidence of SAT was compared
between those treated with two-stent procedure and single stent pro-
cedure. SATwas deﬁned as stent thrombosis which occurs fromone day
to one month after procedure according to the Academic Research
Consortium deﬁnition. The patients whose cause of stent thrombosis
was diagnosed as heparin-induced thrombocytopenia were excluded.
RESULTS SAT occurred in 12 (0.54%) of the 2241 STEMI patients, 13
(0.42%) of the 3098 NSTE-ACS patients and 35 (0.26%) of the 13392
elective patients. And data are shown in the ﬁgure.
CONCLUSION The incidence of SAT was signiﬁcantly higher in STEMI
patients than in elective patients. The difference was remarkable in
those treated with two-stent procedure but not signiﬁcant in those
treated with single stent procedure.
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BACKGROUND The prognosis of ST-segment Elevation Myocardial
Infarction (STEMI) remains hugely different. Risk stratiﬁcation is
therefore very important for individual patient in terms of prognostic
estimation and medical regiment planning. However, the ways for
stratiﬁcation are far from uniform. Evaluations are made based on
different considerations but largely dependent on doctors’ own expe-
riences. We presumed that a classiﬁcation based on different patho-
physiological stages would be an objective way to stratify patients.
METHODS 140 ﬁrst-STEMI patients were classiﬁed as: grade 0, no
detectable myocardial necrosis; grade 1, with myocardial necrosis;
grade 2, myocardial necrosis with reduced left ventricular ejection
fractions (LVEF); grade 3, reduced LVEF accompanied with cardiac
remodeling; grade 4, apparent mitral regurgitation additional to the
grade-3 criteria. To guarantee the equal comparison, myocardial ne-
crosis, infarction size and cardiac remodeling was determined by
cardiac magnetic resonance while mitral regurgitation and cardiac
improvements were assessed by echocardiography.RESULTS 1.4%, 42.1%, 27.2%, 25% and 4.3% patients were classiﬁed
as grade 0 to grade 4, respectively. According rate of 90-day MACEs
(any death, resuscitated cardiac arrest, acute heart failure and stroke)
was 0%,5.1%, 7.9%, 47.1% and 71.4% (p<0.001). Grade-2 patients had
more LVEF improvements than grade-3/4 patients after 90 days
(44.7% vs 18.4%, p<0.001). Both the classiﬁcation and the infarction
size were independent predictors for 90-day MACEs. However,
without the necessity to quantify infarction extent directly, the clas-
siﬁcation is a good reﬂection of infarction size (00%, 16.789.49%,
24.5310.18%, 36.5913.05% and 40.3315.82% by grade 0 to 4,
P<0.001) and has a comparable prognostic value as the infarction
size(0.822 vs. 0.815, p¼0.855 by C-statistics).
CONCLUSION The new classiﬁcation may provide a standard scale to
describe the impact of STEMI on individual patient and facilitate
diagnostic consensus among doctors.
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BACKGROUND Newer-generation DES may be considered the stan-
dard of care for the treatment of STEMI patients undergoing primary
PCI. However, the implantation of these permanent devices can be
associated with important limitations in this setting. The bio-
resorbable vascular scaffold (Absorb BVS) has been designed to
overcome their limitations, disappearing entirely within 3 years and
restoring native vessel state. In this multicentre prospective registry
we sought to evaluate the immediate and midterm clinical outcomes
following single or multiple overlapping BVS implantation in the
STEMI setting.
METHODS A prospective cohort analysis was performed on all STEMI
patients (symptom onset <24 hours from hospital admission) who
underwent primary PCI with BVS implantation in different Italian
Hospitals. The primary endpoint of the study was procedural success,
deﬁned as BVS implantation at the “culprit” lesion site with less than
30% ﬁnal stenosis and TIMI 3 ﬂow without in-hospital MACE (cardiac
death, myocardial infarction [MI] or need for emergent target lesion
revascularization [TLR]). Furthermore, we evaluated the occurrence
of cardiac death, MI, TLR and BVS thrombosis up to 9-month follow-
up.
RESULTS Between December 2012 and February 2014, 1,232 STEMI
patients underwent primary PCI. Of these, 74 (6.0%) received a BVS,
18 (24.3%) of them were multiple and overlapping. Procedural success
was obtained in 72 (97.3%) cases without differences between the
groups (overlapping BVS100% vs. single BVS 96.4%, p¼0.5). One pa-
tient experienced a re-infarction due to sub-acute BVS thrombosis
while the other patient had a ﬁnal TIMI ﬂow 2. At 9-month follow-up,
2 non-fatal MI (2.7%), 3 TLR (4.1%), and 1 sub-acute BVS thrombosis
were reported in 3 patients (1 [5.6%] overlapping BVS and 2 [3.6%] in
the single BVS group, p¼0.5). All the events were successfully
managed with re-PCI.
CONCLUSION Single or multiple overlapping BVS implantation in
STEMI patients can be successfully performed with a high procedural
success rate and encouraging 9-month outcomes. Larger randomized
trials and longer follow-up are needed to assess the potential clinical
beneﬁt of BVS versus new-generation DES in this setting.
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BACKGROUND Acute myocardial infarction without ST segment
elevation (NSTEMI) is the most common form of presentation of acute
myocardial necrosis. Optimal therapeutic strategy in NSTEMI patients
is a subject of debate – it has been shown recently that disturbed
myocardial perfusion in the non-target coronary arteries is associated
with worse prognosis and potential beneﬁts of expanding the primary
intervention to full instead of target-vessel revascularization are be-
ing discussed. The aim of this study is to compare the incidence of
